<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35015250</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>06</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-1182</ISSN><JournalIssue CitedMedium="Internet"><Volume>59</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Molecular neurobiology</Title><ISOAbbreviation>Mol Neurobiol</ISOAbbreviation></Journal><ArticleTitle>piRNA/PIWI Protein Complex as a Potential Biomarker in Sporadic Amyotrophic Lateral Sclerosis.</ArticleTitle><Pagination><StartPage>1693</StartPage><EndPage>1705</EndPage><MedlinePgn>1693-1705</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12035-021-02686-2</ELocationID><Abstract><AbstractText>The pathological hallmark of the majority of amyotrophic lateral sclerosis (ALS) cases is the mislocalization and aggregation of TAR DNA-binding protein 43 (TDP-43), an RNA-binding protein. Several studies have attributed disease processes of ALS to abnormal RNA metabolism. However, dysregulated biogenesis of RNA, especially non-coding RNA (ncRNA), is poorly understood. To resolve it, RNA-Seq, biochemical, and immunohistochemical analyses were performed on the pyramidal tract of the medulla oblongata of sporadic ALS (sALS) and control postmortem brain samples. Here, we report perturbation of ncRNA biogenesis in PIWI-interacting RNA (piRNA) in several sALS brain samples associated with TDP-43 pathology. In addition, we confirmed the dysregulation of two PIWI homologs, PIWI-like-mediated gene silencing 1 (PIWIL1) and PIWIL4, which bind to piRNAs to regulate their expression. PIWIL1 was mislocalized and co-localized with TDP-43 in motor neurons of sporadic ALS lumbar cords. Our results imply that dysregulation of piRNA, PIWIL1, and PIWIL4 is linked to pathogenesis of ALS. Based on these results, piRNAs and PIWI proteins are potential diagnostic biomarkers and therapeutic targets of ALS.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abdelhamid</LastName><ForeName>Rehab F</ForeName><Initials>RF</Initials><AffiliationInfo><Affiliation>Department of Neurology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurotherapeutics, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogawa</LastName><ForeName>Kotaro</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Statistical Genetics, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beck</LastName><ForeName>Goichi</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ikenaka</LastName><ForeName>Kensuke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takeuchi</LastName><ForeName>Eriko</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yasumizu</LastName><ForeName>Yoshiaki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Experimental Immunology, Osaka University Immunology Frontier Research Center, Suita, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jinno</LastName><ForeName>Jyunki</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kimura</LastName><ForeName>Yasuyoshi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baba</LastName><ForeName>Kousuke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagai</LastName><ForeName>Yoshitaka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurotherapeutics, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Faculty of Medicine, Kindai University, Osakasayama, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okada</LastName><ForeName>Yukinori</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Statistical Genetics, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saito</LastName><ForeName>Yuko</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neuropathology (Brain Bank for Aging Research), Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Itabashi, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murayama</LastName><ForeName>Shigeo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neuropathology (Brain Bank for Aging Research), Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Itabashi, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brain Bank for Neurodevelopmental, Molecular Research Center for Children's Mental Development, Neurological and Psychiatric Disorders, Osaka University United Graduate School of Child Development, Suita, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mochizuki</LastName><ForeName>Hideki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagano</LastName><ForeName>Seiichi</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0826-177X</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan. nagano@neurol.med.osaka-u.ac.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurotherapeutics, Osaka University Graduate School of Medicine, Suita, Osaka, Japan. nagano@neurol.med.osaka-u.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>22590932</GrantID><Agency>Grants-in-Aid for Scientific Research (C)</Agency><Country/></Grant><Grant><GrantID>25461302</GrantID><Agency>Grants-in-Aid for Scientific Research (C)</Agency><Country/></Grant><Grant><GrantID>16K09690</GrantID><Agency>Grants-in-Aid for Scientific Research (C)</Agency><Country/></Grant><Grant><GrantID>16H06277</GrantID><Agency>Grant-in-Aid for Scientific Research on Innovative Areas</Agency><Country/></Grant><Grant><GrantID>JP20lm0203007</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant><Grant><GrantID>JP20ek0109320</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant><Grant><GrantID>JP18dm0107103</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Neurobiol</MedlineTA><NlmUniqueID>8900963</NlmUniqueID><ISSNLinking>0893-7648</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D060565">Argonaute Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C421088">PIWIL1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060565" MajorTopicYN="N">Argonaute Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034741" MajorTopicYN="N">RNA, Small Interfering</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">PIWI protein</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">miRNA</Keyword><Keyword MajorTopicYN="N">piRNA</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>11</Day><Hour>12</Hour><Minute>34</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35015250</ArticleId><ArticleId IdType="pmc">PMC8882100</ArticleId><ArticleId IdType="doi">10.1007/s12035-021-02686-2</ArticleId><ArticleId IdType="pii">10.1007/s12035-021-02686-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mejzini R, Flynn LL, Pitout IL, Fletcher S, Wilton SD, Akkari PA, et al. ALS genetics, mechanisms, and therapeutics: where are we now? Front Neurosci. 2019;13:1310. doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad A, Bharathi V, Sivalingam V, Girdhar A, Patel BK, et al. Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis. Front Mol Neurosci. 2019;12:25. doi: 10.3389/fnmol.2019.00025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00025</ArticleId><ArticleId IdType="pmc">PMC6382748</ArticleId><ArticleId IdType="pubmed">30837838</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakisaka KT, Imai Y. The dawn of pirna research in various neuronal disorders. Front Biosci Landmark Ed. 2019;24:1440&#x2013;1451. doi: 10.2741/4789.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/4789</ArticleId><ArticleId IdType="pubmed">31136989</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q, Fan L, Wang X, Lin X, et al. Transcriptome-wide piRNA profiling in human brains for aging genetic factors. Jacobs J Genet. 2019;4:014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7059831</ArticleId><ArticleId IdType="pubmed">32149191</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Del Tredici K, Toledo JB, et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol. 2013;74:20&#x2013;38. doi: 10.1002/ana.23937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23937</ArticleId><ArticleId IdType="pmc">PMC3785076</ArticleId><ArticleId IdType="pubmed">23686809</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin M (2011) Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet Journal 17:10. 10.14806/ej.17.1.200</Citation></Reference><Reference><Citation>Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinforma Oxf Engl. 2014;30:2114&#x2013;2120. doi: 10.1093/bioinformatics/btu170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btu170</ArticleId><ArticleId IdType="pmc">PMC4103590</ArticleId><ArticleId IdType="pubmed">24695404</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitchen R. exceRpt: The extra-cellular RNA processing toolkit. Includes software to preprocess, align, quantitate, and normalise smallRNA-seq datasets. https://rkitchen.github.io/exceRpt/</Citation></Reference><Reference><Citation>Waller R, Wyles M, Heath PR, et al. Small RNA sequencing of sporadic amyotrophic lateral sclerosis cerebrospinal fluid reveals differentially expressed miRNAs related to neural and glial activity. Front Neurosci. 2018;11:731. doi: 10.3389/fnins.2017.00731.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00731</ArticleId><ArticleId IdType="pmc">PMC5767269</ArticleId><ArticleId IdType="pubmed">29375285</ArticleId></ArticleIdList></Reference><Reference><Citation>Waller R, Goodall EF, Milo M, et al. Serum miRNAs miR-206, 143&#x2013;3p and 374b&#x2013;5p as potential biomarkers for amyotrophic lateral sclerosis (ALS) Neurobiol Aging. 2017;55:123&#x2013;131. doi: 10.1016/j.neurobiolaging.2017.03.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.03.027</ArticleId><ArticleId IdType="pmc">PMC5455071</ArticleId><ArticleId IdType="pubmed">28454844</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A, M&#xfc;ller K, Ludolph AC, Weishaupt JH. Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis. Acta Neuropathol Commun. 2013;1:42. doi: 10.1186/2051-5960-1-42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2051-5960-1-42</ArticleId><ArticleId IdType="pmc">PMC3893596</ArticleId><ArticleId IdType="pubmed">24252274</ArticleId></ArticleIdList></Reference><Reference><Citation>Girard A, Sachidanandam R, Hannon GJ, Carmell MA. A germline-specific class of small RNAs binds mammalian Piwi proteins. Nature. 2006;442:199&#x2013;202. doi: 10.1038/nature04917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04917</ArticleId><ArticleId IdType="pubmed">16751776</ArticleId></ArticleIdList></Reference><Reference><Citation>Vagin VV, Sigova A, Li C, et al. A distinct small RNA pathway silences selfish genetic elements in the germline. Science. 2006 doi: 10.1126/science.1129333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1129333</ArticleId><ArticleId IdType="pubmed">16809489</ArticleId></ArticleIdList></Reference><Reference><Citation>Piuco R, Galante PAF. piRNAdb. https://www.pirnadb.org/index</Citation></Reference><Reference><Citation>Wang J, Zhang P, Lu Y, et al. piRBase: a comprehensive database of piRNA sequences. Nucleic Acids Res. 2019;47:D175&#x2013;D180. doi: 10.1093/nar/gky1043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1043</ArticleId><ArticleId IdType="pmc">PMC6323959</ArticleId><ArticleId IdType="pubmed">30371818</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagano S, Jinno J, Abdelhamid RF, et al. TDP-43 transports ribosomal protein mRNA to regulate axonal local translation in neuronal axons. Acta Neuropathol (Berl) 2020;140:695&#x2013;713. doi: 10.1007/s00401-020-02205-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02205-y</ArticleId><ArticleId IdType="pubmed">32803350</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka S, Siomi MC, Siomi H. piRNA clusters and open chromatin structure. Mob DNA. 2014;5:22. doi: 10.1186/1759-8753-5-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1759-8753-5-22</ArticleId><ArticleId IdType="pmc">PMC4131230</ArticleId><ArticleId IdType="pubmed">25126116</ArticleId></ArticleIdList></Reference><Reference><Citation>Dufourt J, Bontonou G, Chartier A, et al. piRNAs and Aubergine cooperate with Wispy poly(A) polymerase to stabilize mRNAs in the germ plasm. Nat Commun. 2017;8:1305. doi: 10.1038/s41467-017-01431-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-01431-5</ArticleId><ArticleId IdType="pmc">PMC5670238</ArticleId><ArticleId IdType="pubmed">29101389</ArticleId></ArticleIdList></Reference><Reference><Citation>Pezic D, Manakov SA, Sachidanandam R, Aravin AA. piRNA pathway targets active LINE1 elements to establish the repressive H3K9me3 mark in germ cells. Genes Dev. 2014;28:1410&#x2013;1428. doi: 10.1101/gad.240895.114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.240895.114</ArticleId><ArticleId IdType="pmc">PMC4083086</ArticleId><ArticleId IdType="pubmed">24939875</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandi S, Chandramohan D, Fioriti L, et al. Roles for small noncoding RNAs in silencing of retrotransposons in the mammalian brain. Proc Natl Acad Sci. 2016;113:12697&#x2013;12702. doi: 10.1073/pnas.1609287113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1609287113</ArticleId><ArticleId IdType="pmc">PMC5111663</ArticleId><ArticleId IdType="pubmed">27791114</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam OH, Ostrow LW, Gale Hammell M. Diseases of the nERVous system: retrotransposon activity in neurodegenerative disease. Mob DNA. 2019;10:32. doi: 10.1186/s13100-019-0176-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13100-019-0176-1</ArticleId><ArticleId IdType="pmc">PMC6659213</ArticleId><ArticleId IdType="pubmed">31372185</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas-R&#xed;os P, Simonelig M. piRNAs and PIWI proteins: regulators of gene expression in development and stem cells. Development. 2018;145:dev161786. doi: 10.1242/dev.161786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.161786</ArticleId><ArticleId IdType="pubmed">30194260</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao P, Yao M, Chang S, et al. Novel function of PIWIL1 in neuronal polarization and migration via regulation of microtubule-associated proteins. Mol Brain. 2015;8:39. doi: 10.1186/s13041-015-0131-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-015-0131-0</ArticleId><ArticleId IdType="pmc">PMC4477296</ArticleId><ArticleId IdType="pubmed">26104391</ArticleId></ArticleIdList></Reference><Reference><Citation>Frost B, Hemberg M, Lewis J, Feany MB. Tau promotes neurodegeneration through global chromatin relaxation. Nat Neurosci. 2014;17:357&#x2013;366. doi: 10.1038/nn.3639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3639</ArticleId><ArticleId IdType="pmc">PMC4012297</ArticleId><ArticleId IdType="pubmed">24464041</ArticleId></ArticleIdList></Reference><Reference><Citation>Godena VK, Romano G, Romano M, et al. TDP-43 Regulates Drosophila neuromuscular junctions growth by modulating futsch/MAP1B levels and synaptic microtubules organization. PLoS ONE. 2011;6:e17808. doi: 10.1371/journal.pone.0017808.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0017808</ArticleId><ArticleId IdType="pmc">PMC3055892</ArticleId><ArticleId IdType="pubmed">21412434</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasperini C, Pelizzoli R, Van AL et al (2020) The piRNA pathway sustains adult neurogenesis by repressing protein synthesis.&#xa0;10.1101/2020.09.15.297739</Citation></Reference><Reference><Citation>Iossifov I, O&#x2019;Roak BJ, Sanders SJ, et al. The contribution of de novo coding mutations to autism spectrum disorder. Nature. 2014;515:216&#x2013;221. doi: 10.1038/nature13908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13908</ArticleId><ArticleId IdType="pmc">PMC4313871</ArticleId><ArticleId IdType="pubmed">25363768</ArticleId></ArticleIdList></Reference><Reference><Citation>Subhramanyam CS, Cao Q, Wang C, et al. Role of PIWI-like 4 in modulating neuronal differentiation from human embryonal carcinoma cells. RNA Biol. 2020;17:1613&#x2013;1624. doi: 10.1080/15476286.2020.1757896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2020.1757896</ArticleId><ArticleId IdType="pmc">PMC7567516</ArticleId><ArticleId IdType="pubmed">32372724</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>